Provided by Tiger Trade Technology Pte. Ltd.

Amcor plc

8.62
+0.11001.29%
Post-market: 8.60-0.0200-0.23%19:58 EST
Volume:18.50M
Turnover:159.31M
Market Cap:19.90B
PE:26.88
High:8.65
Open:8.51
Low:8.50
Close:8.51
52wk High:10.71
52wk Low:7.67
Shares:2.31B
Float Shares:2.29B
Volume Ratio:0.64
T/O Rate:0.81%
Dividend:0.51
Dividend Rate:5.91%
EPS(TTM):0.3207
EPS(LYR):0.3210
ROE:7.47%
ROA:3.54%
PB:1.70
PE(LYR):26.86

Loading ...

Amcor PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Oct 07

Assessing Amcor (NYSE:AMCR) Valuation as Momentum Fades and Analysts See Upside Potential

Simply Wall St.
·
Oct 03

Amcor Investors Appear Too Worried by Volume Declines -- Market Talk

Dow Jones
·
Oct 02

Amcor PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 30

Amcor PLC Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 27

Amcor plc Adopts New Executive Change-in-Control Severance Plan with Enhanced Protections for Top Officers

Reuters
·
Sep 26

Amcor PLC Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 24

Amcor plc Announces Date for Upcoming Annual General Meeting

Reuters
·
Sep 24

Amcor Faces 'Challenged' Packaging Sector, Lower Synergies From Berry Acquisition, RBC Says

MT Newswires Live
·
Sep 23

Amcor Offers Long-Term Value But Challenges Persist -- Market Talk

Dow Jones
·
Sep 23

Amcor initiated with a Sector Perform at RBC Capital

TIPRANKS
·
Sep 23

Amcor’s Growth Potential: Buy Rating Backed by Merger Synergies and Strong Cash Flow

TIPRANKS
·
Sep 19

Amcor Plc : JP Morgan Assumes Coverage With Overweight Rating; Target Price $10.00

THOMSON REUTERS
·
Sep 19

Amcor PLC Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Sep 17

Amcor PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 12

Amcor plc Announces Date for Annual General Meeting of Shareholders

Reuters
·
Sep 12

Jefferies Keeps Their Buy Rating on Amcor (AMCR)

TIPRANKS
·
Sep 11

Amcor PLC Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 03

JPMorgan Adjusts Price Target on Amcor to $11.10 From $12.40, Maintains Overweight Rating

MT Newswires Live
·
Sep 02

Innocan Pharma Reports 4% Revenue Decline in H1 2025, Achieves 130% Increase in Operating Profit

Reuters
·
Aug 28